New FDA approvals and emerging trial data drive two pivotal 2026 NCCN guideline updates: lutetium-177 PSMA-617 for ...

March 31, 2026News Release KDIGO publishes 2026 Clinical Practice Guideline Draft for Acute Kidney Injury and Acute Kidney Disease COPENHAGEN, DENMARK, 31 March 2026 – BioPorto A/S (“BioPorto” or ...

A new brain–heart clinical practice guideline takes a holistic approach, integrating neurologic and mental health evidence with guidance for cardiovascular disease as many brain and heart conditions ...

Visit NAP.edu/10766 to get more information about this book, to buy it in print, or to download it as a free PDF. Clinicians can no longer stay abreast of the rapidly expanding knowledge bases related ...

Background: Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos.

ImmunityBio Inc. (NASDAQ:IBRX) is one of the best NASDAQ stocks under $30 to buy. On March 17, ImmunityBio announced that the National Comprehensive Cancer Network/NCCN updated its 2026 Clinical ...

For every 1,000 patients in the study cohort, 497 (49.7%) are lost to precision oncology because of factors associated with getting biomarker test results. Among the 503 of 1,000 patients who did ...

Updated guidance incorporates new research to address nonoperative management of BTAI, timing of repair & managing ...

Nick Mireles is a writer on the central coast of California. He has a knack for film, music, and Dungeons and Dragons. When he’s not writing, he tries to spend his days reading, surfing, and camping ...